Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2217/3dp-2020-0013 http://scihub22266oqcxt.onion/10.2217/3dp-2020-0013 C7720651!7720651!C7720651     free     free     free       J+3D+Print+Med ä ; ä (ä): ä Nephropedia Template TP {{tp|p=C7720651|t=ä. COVID-19: additive manufacturing response in the UK |pdf=|usr=}}{{C7720651}} gab.com Text COVID-19: additive manufacturing response in the UK JO: J 3D Print Med http://www.kidney.de/pget.php?&tw=1&pmid=C7720651 #FOAvip Severe acute respiratory syndrome coronavirus 2, a novel coronavirus, caused global disruption specifically in linear supply chains. Increased demand for already disrupted services led to a global shortage of medical equipment and personal protective equipment. Use of additive manufacturing (AM) processes by the manufacturing community has shown great innovation, agility and flexibility to fill supply chain gaps and meet shortfalls. In the context of contingency reaction to a global healthcare emergency, decisions have had to be made quickly, in some cases bypassing device safety regulations. This concentrated and spontaneous use of AM has highlighted the challenges and risks of such innovation, which we discuss in relation to the UK?s current regulatory landscape. We have discussed lessons learned and the potential future impact upon wider use of AM in healthcare. Twit Text FOAVip COVID-19: additive manufacturing response in the UK ????J 3D Print Med http://www.kidney.de/pget.php?&tw=1&pmid=C7720651 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=C7720651 #FOAvip English Wikipedia <ref>{{Cite pmid|C7720651}}</ref> COVID-19: additive manufacturing response in the UK #MMPMIDC7720651 Parry EJ; Banks CE J 3D Print Med ä[]; ä (ä): ä PMIDC7720651show ga Severe acute respiratory syndrome coronavirus 2, a novel coronavirus, caused global disruption specifically in linear supply chains. Increased demand for already disrupted services led to a global shortage of medical equipment and personal protective equipment. Use of additive manufacturing (AM) processes by the manufacturing community has shown great innovation, agility and flexibility to fill supply chain gaps and meet shortfalls. In the context of contingency reaction to a global healthcare emergency, decisions have had to be made quickly, in some cases bypassing device safety regulations. This concentrated and spontaneous use of AM has highlighted the challenges and risks of such innovation, which we discuss in relation to the UK?s current regulatory landscape. We have discussed lessons learned and the potential future impact upon wider use of AM in healthcare. äCOVID-19: additive manufacturing response in the UK (epmc).pdf DeepDyve Pubget Overpricing